Total Payments
$115,198
2024 Payments
$7,275
Companies
27
Transactions
347
Medicare Patients
7,233
Medicare Billing
$478,390
Payment Breakdown by Category
Other$59,326 (51.5%)
Consulting$20,913 (18.2%)
Travel$16,934 (14.7%)
Food & Beverage$16,342 (14.2%)
Research$1,632 (1.4%)
Education$51.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $59,178 | 29 | 51.4% |
| Consulting Fee | $20,913 | 10 | 18.2% |
| Travel and Lodging | $16,934 | 75 | 14.7% |
| Food and Beverage | $16,342 | 217 | 14.2% |
| Unspecified | $1,632 | 8 | 1.4% |
| Entertainment | $147.61 | 3 | 0.1% |
| Education | $51.97 | 5 | 0.0% |
Payments by Type
General
$113,566
339 transactions
Research
$1,632
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $33,839 | 90 | $0 (2024) |
| Amgen Inc. | $25,325 | 51 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $18,099 | 22 | $0 (2019) |
| Esperion Therapeutics, Inc. | $12,366 | 18 | $0 (2021) |
| Avinger Inc. | $5,034 | 37 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $4,840 | 13 | $0 (2019) |
| Bard Peripheral Vascular, Inc. | $3,011 | 21 | $0 (2018) |
| Abbott Laboratories | $2,120 | 19 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $1,632 | 8 | $0 (2017) |
| W. L. Gore & Associates, Inc. | $1,379 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,275 | 24 | Boston Scientific Corporation ($5,772) |
| 2023 | $11,743 | 54 | Boston Scientific Corporation ($7,547) |
| 2022 | $1,618 | 24 | Avinger Inc. ($876.83) |
| 2021 | $7,898 | 27 | Esperion Therapeutics, Inc. ($3,714) |
| 2020 | $9,182 | 16 | Esperion Therapeutics, Inc. ($8,652) |
| 2019 | $26,182 | 68 | Amgen Inc. ($10,903) |
| 2018 | $24,143 | 56 | Amgen Inc. ($8,247) |
| 2017 | $27,156 | 78 | BOSTON SCIENTIFIC CORPORATION ($6,972) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $129.28 | General |
| Category: AVVIGO_IC | ||||||
| 08/13/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: AVVIGO_IC | ||||||
| 08/01/2024 | Abbott Laboratories | SUPERA (Device) | Travel and Lodging | In-kind items and services | $66.00 | General |
| Category: Vascular | ||||||
| 08/01/2024 | Abbott Laboratories | SUPERA (Device) | Travel and Lodging | In-kind items and services | $58.37 | General |
| Category: Vascular | ||||||
| 08/01/2024 | Abbott Laboratories | SUPERA (Device) | Food and Beverage | In-kind items and services | $35.33 | General |
| Category: Vascular | ||||||
| 08/01/2024 | Abbott Laboratories | SUPERA (Device) | Travel and Lodging | In-kind items and services | $5.96 | General |
| Category: Vascular | ||||||
| 07/26/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: ELUVIA_PI | ||||||
| 06/18/2024 | Abbott Laboratories | ABSOLUTE PRO (Device) | Food and Beverage | In-kind items and services | $125.95 | General |
| Category: Vascular | ||||||
| 05/23/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: Vascular | ||||||
| 05/22/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: Vascular | ||||||
| 05/22/2024 | Abbott Laboratories | SUPERA (Device) | Food and Beverage | In-kind items and services | $53.16 | General |
| Category: Vascular | ||||||
| 05/08/2024 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Travel and Lodging | In-kind items and services | $795.64 | General |
| Category: Vascular | ||||||
| 05/08/2024 | Abbott Laboratories | PERCLOSE PROGLIDE (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Vascular | ||||||
| 03/01/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $4,250.00 | General |
| Category: General - Therapies_PI | ||||||
| 03/01/2024 | Boston Scientific Corporation | — | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: General - Therapies_PI | ||||||
| 03/01/2024 | Boston Scientific Corporation | — | Food and Beverage | Cash or cash equivalent | $29.02 | General |
| Category: General - Therapies_PI | ||||||
| 02/21/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $82.48 | General |
| Category: ELUVIA_PI | ||||||
| 02/21/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ELUVIA_PI | ||||||
| 02/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $137.56 | General |
| Category: General - Therapies_PI | ||||||
| 02/08/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $583.33 | General |
| Category: General - Therapies_PI | ||||||
| 02/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $248.01 | General |
| Category: General - Therapies_PI | ||||||
| 02/08/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $212.80 | General |
| Category: General - Therapies_PI | ||||||
| 01/09/2024 | Philips North America LLC | (4066) Tack Endovascular Systems ATK (Device) | Food and Beverage | Cash or cash equivalent | $24.94 | General |
| Category: Medical Device | ||||||
| 12/22/2023 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: General - Therapies_PI | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECT OF PRALUENT ON NEUROCOGNITIVE FUNCTION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA OR WITH NON-FAMILIAL HYPERCHOLESTEROLEMIA AT HIGH AND VERY HIGH CARDIOVASCULAR RISK | Regeneron Pharmaceuticals, Inc. | $1,632 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,491 | 1,723 | $467,145 | $105,579 |
| 2022 | 18 | 1,953 | 2,333 | $381,847 | $104,172 |
| 2021 | 23 | 1,862 | 2,187 | $483,592 | $130,444 |
| 2020 | 21 | 1,927 | 2,354 | $558,442 | $138,195 |
Total Patients
7,233
Total Services
8,597
Medicare Billing
$478,390
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 335 | $63,650 | $28,396 | 44.6% |
| 37225 | Removal of plaque in arteries of leg | Facility | 2023 | 25 | 29 | $164,923 | $12,621 | 7.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 133 | $20,349 | $12,359 | 60.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 155 | $18,600 | $9,622 | 51.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 66 | $19,800 | $8,847 | 44.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 12 | 16 | $24,528 | $6,094 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 103 | $13,802 | $5,498 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 42 | $11,172 | $5,264 | 47.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 23 | 23 | $16,649 | $4,290 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 285 | 306 | $24,174 | $2,836 | 11.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 244 | 270 | $8,640 | $1,678 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,458 | $1,572 | 45.5% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Facility | 2023 | 18 | 19 | $62,320 | $1,329 | 2.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 25 | 25 | $4,400 | $1,279 | 29.1% |
| 75710 | Review by radiologist of arm or leg artery image | Facility | 2023 | 15 | 15 | $2,205 | $976.20 | 44.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 24 | 25 | $1,775 | $752.75 | 42.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 30 | 30 | $1,710 | $492.60 | 28.8% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 16 | 16 | $1,136 | $469.12 | 41.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 12 | 12 | $852.00 | $329.89 | 38.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 30 | 30 | $1,110 | $326.70 | 29.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 12 | 12 | $492.00 | $219.96 | 44.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 32 | 34 | $1,088 | $210.25 | 19.3% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 13 | $312.00 | $116.09 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 284 | 353 | $67,070 | $29,128 | 43.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 134 | 240 | $36,720 | $18,767 | 51.1% |
About Dr. Gary Fishbein, MD
Dr. Gary Fishbein, MD is a Cardiovascular Disease healthcare provider based in Centerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184626384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Fishbein, MD has received a total of $115,198 in payments from pharmaceutical and medical device companies, with $7,275 received in 2024. These payments were reported across 347 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($59,178).
As a Medicare-enrolled provider, Fishbein has provided services to 7,233 Medicare beneficiaries, totaling 8,597 services with total Medicare billing of $478,390. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Centerville, OH
- Active Since 06/01/2005
- Last Updated 03/22/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1184626384
Products in Payments
- Repatha (Biological) $25,281
- PRALUENT (Drug) $18,068
- NEXLIZET (Drug) $12,333
- PRALUENT (Biological) $4,840
- GENERAL THERAPIES (Device) $4,430
- PANTHERIS (Device) $4,408
- GENERAL VASCULAR INTERVENTION (Device) $3,165
- GENERAL VASCULAR INTERVENTION (Device) $3,057
- GENERAL - STENTS (Device) $3,022
- CLINICAL TRIAL PRODUCT (Device) $2,281
- ELIQUIS (Drug) $1,637
- PRALUENT ALIROCUMAB INJECTION (Biological) $1,632
- GENERAL - ATHERECTOMY (Device) $1,379
- EXCLUDER Iliac Branch Endoprosthesis (Device) $1,322
- GENERAL THERAPIES (Device) $1,274
- LEQVIO (Drug) $1,091
- Impella (Device) $940.72
- PERCLOSE PROGLIDE (Device) $804.66
- General - Vascular Intervention (Device) $607.17
- GENERAL - VASCULAR INTERVENTION (Device) $375.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.